NURS 6630N Midterm Exam Week 6 - 100% Verified Questions and Answers
Question 1
1 out of 1 points
A patient is being prescribed a sedating
... [Show More] antidepressant, but is concerned about weight gain. Which medication is most likely to be prescribed to addresses the patient’s concerns?
Selected Answer: D.
trazadone (Oleptro)
Question 2
1 out of 1 points
Which statement made by the PMHNP exemplifies correct teaching of physiological effects in the body?
Selected Answer: D.
D2 partial agonists are associated with increased efficacy in treating positive symptoms of schizophrenia.
Question 3
1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to monitor for which possible effect?
Selected Answer: D.
All of the above
Question 4
1 out of 1 points
Which statement about neurotransmitters and medications is true?
Selected Answer: B.
Several psychiatric medications have been developed after discoveries of endogenous neurotransmitters and defining their function in the brain.
Question 5
1 out of 1 points
Mrs. Trevor is a 44-year-old patient who does not have a diagnosis of schizophrenia but occasionally reports symptoms of psychosis, followed by severe fatigue. Mrs. Trevor inquires about the use of amphetamines to help with her energy levels. Which response made by the PMHNP is most appropriate?
Selected Answer: C.
“Amphetamines can cause hallucinations, so I would advise against this type of prescription.”
Question 6
1 out of 1 points
The PMHNP is caring for several patients who present with various symptoms and health issues. For which patient does the PMHNP prescribe pregabalin (Lyrica)?
Selected Answer: B.
Patient with partial seizures
Question 7
1 out of 1 points
As it relates to G-protein linked receptors, what does the PMHNP understand about medications that are used in practice?
Selected Answer: A.
Most medications that act on G-protein linked receptors have antagonistic traits.
Question 8
0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin taking medication again to treat her bipolar depression; she is breastfeeding her 2-month old daughter. The PMHNP recognizes that which of the following medications is contraindicated for this patient?
Selected Answer: C.
Lithium (Lithobid)
Question 9
1 out of 1 points
The PMHNP understands that the potential of alcohol abuse in the anxious client is higher for the following reasons:
Selected Answer: a.
Alcohol exerts an effect on GABAA receptors.
Question 10
1 out of 1 points
A 25-year-old female patient is being prescribed milnacipran to treat fibromyalgia, and expresses concern regarding “how she will feel and look” from taking the medicine. Which statement correctly describes the side effects as a result of taking this medication?
Selected Answer: D.
Weight gain is unusual.
Question 11
1 out of 1 points
Mr. Gordon is a middle-aged client who was started on antidepressant monotherapy for depression. After beginning this medication, the PMHNP noticed that this client seemed to swing into a hypomanic episode. What can the PMHNP infer from this behavior change?
Selected Answer: A.
This client may have Bipolar III disorder
Question 12
1 out of 1 points
Mr. McCullin is 64 years old with Parkinson’s disease. The PMHNP caring for Mr. McCullin wants to start him on a dopamine agonist to help manage and treat his condition. The PHMNP selects this agent because of which action it has on patients like Mr. McCullin?
Selected Answer: D.
D2 receptors are the primary binding site for dopamine agonists.
Question 13
0 out of 1 points
The PMHNP recognizes that which patient would be contraindicated for antidepressant monotherapy?
Selected Answer: B.
Patient with a bipolar II designation
Question 14
1 out of 1 points
The PMHNP is caring for a patient with schizophrenia and is considering a variety of treatment approaches. The PHMNP selects a viable treatment that is consistent with the “dopamine hypothesis of schizophrenia.” What action does the PMHNP anticipate this treatment having on the patient?
Selected Answer: B.
Hyperactivity in the mesolimbic dopamine pathway mediates the positive symptoms of schizophrenia.
Question 15
1 out of 1 points
There are a number of endocrine reactions that accompany fear. A quick boost of cortisol may enhance survival when encountering a real but short-term threat. However, chronic elevations in cortisol can lead to increased medical comorbidities. Which of the following medical conditions may be related to these persistent cortisol elevations?
Selected Answer: D.
All of the above
Question 16
1 out of 1 points
A patient who was diagnosed with bipolar disorder without mania, asks the PMHNP why he is being prescribed a mood stabilizer. What is the appropriate response?
Selected Answer: C.
Mood stabilizers can target mania and mania relapse and also reduce symptoms of bipolar depression and relapse of bipolar depression symptoms but no drug has been proven to target all four therapeutic actions
Question 17
1 out of 1 points
The PMHNP is assessing a patient in the psychiatric emergency room. The patient tells the PMHNP that he does not understand why his depression has not lifted after being on four different antidepressants over the course of a year. Which of the following symptoms can be residual symptoms for patients who do not achieve remission with major depressive disorder?
Selected Answer: D.
A and C
Question 18
1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no established history of depression. When meeting with the PMHNP, she presents with apathy and withdrawn social behavior, and she reports a loss of joy from enjoyable activities since starting her new medication. What does the PMHNP infer from this encounter with the client?
Selected Answer: C.
The new medication is blocking D2 receptors in the mesolimbic system
Question 19
1 out of 1 points
The PMHNP is caring for a new patient who has been transferred from another office. When meeting with the new patient, the patient reports, “I feel like I am improving with the stabilizers.” The PMHNP immediately recognizes that the patient is describing which kind of drug?
Selected Answer: C.
Partial agonists
Question 20
1 out of 1 points
A 51-year-old female patient presents with symptoms of depression, including lack of motivation and difficulty sleeping. What risk factors would increase her vulnerability for a diagnosis of depression?
Selected Answer: D.
A and C [Show Less]